Table 2.
SNP ID | Chr 6 position | Gene | Class | MAF | Allele | Haplotype block numberb |
Relation to VL |
---|---|---|---|---|---|---|---|
1st analysisc | |||||||
rs1737004 | 29,869,190 | HCG4|HLA-G | upstream | 0.439 | C | 93 | Low |
rs2394250 | 30,051,635 | HCG9 | ncRNA | 0.282 | T | NA | Low |
rs3129813 | 30,446,226 | RPP21|HLA-E | intergenic | 0.436 | G | NA | High |
rs404860 | 32,292,323 | NOTCH4 | intron | 0.334 | G | 285 | High |
rs3819714 | 32,912,195 | TAP2 | intron | 0.422 | G | 351 | Low |
2nd analysisd | |||||||
rs3094626 | 30,431,602 | RPP21|HLA-E | intergenic | 0.430 | C | 133 | Low |
rs3134931 | 32,298,598 | NOTCH4 | intron | 0.517 | G | NA | High |
Testing additive effects for the minor alleles (nucleotides) of single nucleotide polymorphism (SNPs); Chr, chromosome; MAF, minor allele frequency; VL, viral load
Not all eligible SNPs can be assigned to haplotype blocks (details are shown in Supplemental Materials). NA, not applicable.
First analysis has age and sex as covariates; overall R2=34.4% for the model.
Second analysis has age, sex, HLA-A*74, B*13 and B*57 as covariates; overall R2=28.9 for the model.